Campbell, M.

McCabe, C.

English

White Rose Research Online

This is a repository copy of Repaglinide (NovoNorm) in the management of Type 2 Diabetes.White Rose Research Online URL for this paper:http://eprints.whiterose.ac.uk/124338/Version: Published VersionMonograph:McCabe, C. and Campbell, M. (2000) Repaglinide (NovoNorm) in the management of Type 2 Diabetes. Other. ScHARR Occasional Paper (00/01). ScHARR (School of Health and Related Research), University of Sheffield , Sheffield. ISSN 1900752131 eprints@whiterose.ac.ukhttps://eprints.whiterose.ac.uk/Reuse This article is distributed under the terms of the Creative Commons Attribution-NonCommercial (CC BY-NC) licence. This licence allows you to remix, tweak, and build upon this work non-commercially, and any new works must also acknowledge the authors and be non-commercial. You don’t have to license any derivative works on the same terms. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 

Repaglinide (NovoNorm) in the management of Type 2 Diabetes

https://eprints.whiterose.ac.uk/124338/1/00_01%20Repaglinide%20in%20the%20management%20of%20type%202%20diabetes.pdf

Repaglinide (NovoNorm) in the management of Type 2 Diabetes

Abstract

Similar works

Full text

Available Versions

White Rose Research Online

White Rose Research Online